Efficacy of Alpha Lipoic Acid Combined With Myo-Inositol in Non-Diabetic PCOS Patients
Key facts
- Phase
- Phase 3
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 40 years old?
Source: NCT07630779, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Beni-Suef University
- Trial code
- NCT07630779
- Record updated
- 5 June 2026
- Original description
This study evaluates the efficacy of alpha-lipoic acid combined with myo-inositol, with or without metformin, in improving menstrual regularity and ovulation in non-diabetic women with polycystic ovary syndrome (PCOS). The study also assesses metabolic, hormonal, and clinical outcomes.Read full original descriptionShow less
A Randomized Controlled Trial Evaluating the Efficacy of Alpha Lipoic Acid Combined With Myo-Inositol With or Without Metformin in Non-Diabetic Women With Polycystic Ovary Syndrome
This study evaluates the efficacy of alpha-lipoic acid combined with myo-inositol, with or without metformin, in improving menstrual regularity and ovulation in non-diabetic women with polycystic ovary syndrome (PCOS). The study also assesses metabolic, hormonal, and clinical outcomes.
Inclusion: Women aged 21 to 40 years; Diagnosed with polycystic ovary syndrome (PCOS) according to Rotterdam criteria; Not currently pregnant or lactating; No hormonal therapy within the last 3 months; Willing and able to provide informed consent.
Exclusion: - History of diabetes mellitus, hypertension, or thyroid disorders; History of cardiovascular, renal, or hepatic disease; Known hypersensitivity or allergy to study medications (myo-inositol, alpha-lipoic acid, or metformin); Use of hormonal contraceptives or insulin sensitizers within the last 3 months; Non-Egyptian ethnicity.